Rédiger un PREreview

This study addresses the challenge of effective drug delivery systems in the treatment of HIV and cancer, where precision in targeting diseased cells is critical for optimizing therapeutic outcomes and minimizing side effects. Current methods, including oral and injectable routes, often fail to concentrate drugs specifically at target sites, leading to collateral damage to healthy tissues. Our research employs advanced engineering techniques to develop nanoparticles that deliver drugs directly to HIV-infected or tumor cells, enhancing treatment efficacy. Utilizing lipid-based and polymer-based nanoparticles, we explored their capabilities to encapsulate a range of therapeutic agents and navigate biological barriers. Results indicate that these engineered nanoparticles release their payloads optimally at targeted locations, significantly reducing systemic toxicity while improving drug potency. The implications of our findings highlight the potential of nanoparticle technology to revolutionize treatment paradigms, leading to more personalized healthcare strategies that enhance patient quality of life and therapeutic effectiveness in managing complex diseases like HIV and cancer.